Navigation Links
Dr. Ben Goldacre to Keynote PhUSE Annual Conference
Date:2/7/2013

Brussels, Belgium (PRWEB) February 07, 2013

PhUSE, a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information, is proud to announce that Dr. Ben Goldacre will present the Keynote at the 2013 PhUSE Annual Conference. The 2013 conference focus is ‘Patient Centricity’ in the pharmaceutical world.

As a physician and academic writer Doctor Ben Goldacre will speak to the PhUSE community about how patient centric thinking will help to bring efficacious new drugs to patients. In his latest book "Bad Pharma" Doctor Ben Goldacre gives a critical insight into the 600 billion dollar global pharmaceutical industry. In his keynote Doctor Goldacre will share his views on the process of new drug approval. He will tell the PhUSE community how flaws in the planning, conduct and publication of studies conducted by the pharmaceutical industry can harm the life of patients.

In his keynote for PhUSE, Doctor Goldacre will address the interests of all involved parties: the patients, pharmaceutical drug companies, regulatory bodies and payers.

Discussion groups for conference attendees will expand upon the themes of the keynote, giving attendees the opportunity to learn and share knowledge about creating better outcomes for patients through their work with clinical trial data.

Registration for the conference is open. Sponsorship opportunities are available.

About Doctor Goldacre:
Ben Goldacre is an award-winning writer, broadcaster, and medical doctor who specializes in unpicking scientific claims made by scaremongering journalists, government reports, pharmaceutical corporations, PR companies and quacks. He was trained in Medicine at Oxford and London, and currently works as an academic in epidemiology. Ben wrote the weekly Bad Science column in the Guardian from 2003-2011. Bad Science the book (4th Estate) has sold over half a million copies worldwide, reached #1 in the paperback non-fiction charts, and is being published in 25 languages. In his new book, Bad Pharma (4th Estate, September 2012) Ben puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess.

About PhUSE
PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and eClinical IT professionals.

Read the full story at http://www.prweb.com/releases/BenGoldacre/PhUSEAnnualConference/prweb10400642.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
2. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
3. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
10. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... (PRWEB) , ... June 21, 2017 , ... ... attracting and hiring top executive talent in the life sciences industry, today announces ... Manufacturing company. The partnership takes full advantage of Beaker’s expertise in executive ...
(Date:6/22/2017)... ... 22, 2017 , ... Ovation Fertility supports the American Medical ... new hope for prospective parents who are challenged with costs of treatment. AMA ... Health Organization’s designation in hopes of changing the way health insurers, governments and ...
(Date:6/22/2017)... ... June 22, 2017 , ... RURO, Inc., a leading ... 6.5, a content-packed update to the Limfinity® framework. , LimitLIS® and other RURO ... diverse base of customers among labs and other businesses. Limfinity® 6.5 adds new ...
(Date:6/20/2017)... ... June 20, 2017 , ... HorizonScan is providing food and ... most likely threat to their products at the annual IFT conference in Las ... food expo attracts over 20,000 attendees representing food science professionals from over 90 ...
Breaking Biology Technology:
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
Breaking Biology News(10 mins):